The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis

Author(s): Auletta JJ, Bartholomew AM, Maziarz RT, Deans RJ, Miller RH, et al.

Abstract

Multiple sclerosis (MS) is an inflammatory neurodegenerative disease of the CNS for which only partially effective therapies exist. Intense research defining the underlying immune pathophysiology is advancing both the understanding of MS as well as revealing potential targets for disease intervention. Mesenchymal stromal cell (MSC) therapy has the potential to modulate aberrant immune responses causing demyelination and axonal injury associated with MS, as well as to repair and restore damaged CNS tissue and cells. This article reviews the pathophysiology underlying MS, as well as providing a cutting-edge perspective into the field of MSC therapy based upon the experience of authors intrinsically involved in MS and MSC basic and translational science research.

Similar Articles

Stem cell transplantation in multiple sclerosis: current status and future prospects

Author(s): Martino G, Franklin RJ, Baron Van Evercooren A, Kerr DA; Stem Cells in Multiple Sclerosis (STEMS) Consensus Group

Progress and prospects: stem cells and neurological diseases

Author(s): Gögel S, Gubernator M, Minger SL

Isolation of amniotic stem cell lines with potential for therapy

Author(s): De Coppi P1, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, et al.

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

Author(s): Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, et al.

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

Author(s): Djouad F, Plence P, Bony C, Tropel P, Apparailly F, et al.

Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis

Author(s): Liang J, Zhang H, Hua B, Wang H, Wang J, et al.

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

Author(s): Riordan NH, Ichim TE, Min WP, Wang H, Solano F, et al.

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy

Author(s): Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, et al.

Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis

Author(s): Darlington PJ, Boivin MN, Renoux C, François M, Galipeau J, et al.